Last updated on November 2017

A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus


Brief description of study

A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus

Detailed Study Description

Primary objective:
To demonstrate that morning injection of Toujeo compared to Lantus will provide better glycemic control evaluated by Continuous Glucose Monitoring (CGM) in adult patients with type 1 diabetes mellitus.

Secondary objective(s):
To demonstrate that treatment with Toujeo compared to Lantus will provide

  • lower incidence rate of nocturnal symptomatic hypoglycemia,
  • better glucose control coverage during the last hours of CGM before next basal-insulin dosing;
  • less variability in CGM profile.

Clinical Study Identifier: TX8863

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Vanessa Lombardi

Columbus Regional Research Institute
Columbus, GA USA
  Connect »